Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

Jérôme Lambert; Roberta Di Blasi; Florence Rabian; Marie-Emilie Dourthe; André Baruchel; Catherine Thiéblemont; Nicolas Boissel; Vincent Levy; Marie-Quitterie Picat; Sylvie Chevret

doi:10.1097/HS9.0000000000000873

Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

Hemasphere. 2023 May 29;7(6):e873. doi: 10.1097/HS9.0000000000000873. eCollection 2023 Jun.

Authors

Jérôme Lambert^{1

2

3}, Roberta Di Blasi⁴, Florence Rabian^{3

5

6}, Marie-Emilie Dourthe⁷, André Baruchel^{3

6

7}, Catherine Thiéblemont^{3

4

8}, Nicolas Boissel^{3

5

6}, Vincent Levy^{2

9}, Marie-Quitterie Picat¹, Sylvie Chevret^{1

2

3}

Affiliations

¹ Biostatistic Department, Saint Louis Hospital (APHP), Paris, France.
² ECSTRRA Team, UMR1153, Inserm, Université Paris Cité, Paris, France.
³ Paris Cité University, Paris, France.
⁴ Hemato-oncology Department, Saint Louis Hospital (APHP), Paris, France.
⁵ Unité d'Hématologie Adolescents et Jeunes Adultes, AP-HP, Hôpital Saint Louis, Paris, France.
⁶ URP-3518, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.
⁷ Department of Pediatric Hematology and Immunology, AP-HP, Hôpital Universitaire Robert Debré, Paris, France.
⁸ Université Paris Cité, NF-kappaB, Différenciation et Cancer, Paris, France.
⁹ Centre d'investigations cliniques, Hôpital Avicenne, Bobigny, France.

No abstract available